Genezen has opened its new process development and analytical lab for viral vector production. Genezen, a cell and gene therapy contract development and manufacturing organization, has officially ...
Enhancing Scale-Up, Increasing Quality, and Reducing Costs for AVs, LVVs, AAVs and More The 3rd Viral Vector Process Development and Manufacturing Summit returns to Boston, uniting industry leaders ...
Effective process development for viral vector-based medicines is paramount for optimized process efficiency, robustness, scalability, and product quality. Well-designed processes streamline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback